주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-03-28 16:29 (Thurs)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Bio
목록
(
총 :
642 )
기사목록 보기 형태
제목형
요약형
포토형
Samsung Biologics launches CDO-accelerating platform S-Cellerate
Lee Han-soo
2021.09.23 15:32
Korean, US companies enhance global vaccine partnership
Kwak Sung-sun
2021.09.23 12:08
Samsung Bioepis speeds up release of Lucentis biosimilar
Kim Chan-hyuk
2021.09.23 12:07
EuBiologics to apply for phase 3 trial of Covid-19 vaccine in October
Kim Chan-hyuk
2021.09.17 15:08
‘Samsung Biologics’ digitization enabled FDA’s virtual inspection of Covid-19 drug’
Kim Chan-hyuk
2021.09.16 16:18
Cytiva picks Korea as candidate for Asian production site
Park Gi-taek
2021.09.16 15:12
Things to consider before drawing rosy picture for mRNA vaccine
Kim Chan-hyuk
2021.09.14 15:01
Shareholders approve merger of GC LabCell, GC Cell
Kim Chan-hyuk
2021.09.14 14:58
Samsung Bioepis confirms safety, efficacy of trastuzumab biosimilar for breast cancer
Shim Hyun-tai
2021.09.13 11:44
Samsung Bioepis confident of its biosimilar’s effects on macular degeneration
Shim Hyun-tai
2021.09.10 16:32
Korea’s 1st ‘private-led cluster for new drug development’ to open
Kim Chan-hyuk
2021.09.10 14:32
Genome & Company jumps into CDMO business by acquiring US firm
Shim Hyun-tai
2021.09.08 15:45
처음
이전
이전
이전
51
52
53
54
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기